home / stock / iclr / iclr news


ICLR News and Press, ICON plc From 04/26/22

Stock Information

Company Name: ICON plc
Stock Symbol: ICLR
Market: NASDAQ
Website: iconplc.com

Menu

ICLR ICLR Quote ICLR Short ICLR News ICLR Articles ICLR Message Board
Get ICLR Alerts

News, Short Squeeze, Breakout and More Instantly...

ICLR - Medpace drags rivals after unchanged 2022 guidance

The shares of the Medpace Holdings (NASDAQ:MEDP) have reached a 52-week low on Tuesday after the contract research organization set the 2022 outlook unchanged despite its 1Q 2022 financials that stood above Street forecasts. The peers in the subsector, including ICON (ICLR), IQVIA Holdin...

ICLR - Thermo Fisher downgraded to underweight on valuation at Wells Fargo

Wells Fargo has downgraded life sciences company Thermo Fisher Scientific (NYSE:TMO) to underweight and lowered the price target from $605 to $525, citing an expensive valuation and "material headwinds for the stock ahead". Thermo Fisher (TMO) is trading -4.37% currently and -1...

ICLR - Syneos Health hits a 52-week low after Jefferies downgrade

The shares of Syneos Health (NASDAQ:SYNH) have recorded the worst intraday performance in over two years to reach a 52-week low after Jefferies downgraded the life sciences company to Hold from Buy citing risks to 2022 guidance. Supporting the thesis, the analysts led by David Windley point o...

ICLR - ClearBridge International Growth ADR Strategy Portfolio Manager Commentary Q1 2022

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp spike in bond yields pressured growth stocks and ...

ICLR - Icon, Syneos Health win Buy ratings as Deutsche Bank takes a fresh look at CROs

Despite the recent weakness in contract research organizations, Deutsche Bank opts to take a favorable view on the subsector, citing industry checks. With stocks down 20 – 30% from the November peak and several names hovering near S&P market multiples, “we find the entry poi...

ICLR - Medpace Holdings: Recent Price Dislocation Buying Opportunity

Medpace Holdings is a healthy business trading at a discount to its intrinsic value. Price target $193-200. The company has zero debt vs peer group average of $5.6B debt. Lower risk of permanent loss of capital vs peers. Medpace top-line in the past four years grew at 17.5% CAGR v...

ICLR - Tracking Ron Baron's BAMCO Portfolio - Q4 2021 Update

BAMCO’s 13F portfolio value increased from $44.15B to $47.14B this quarter. Ron Baron increased Taiwan Semi, Iridium Communications, and Spotify while dropping Zillow Group. Their top five positions are at ~27% of the overall portfolio. For further details see: Tr...

ICLR - ICON plc to Webcast Analyst Day Meeting

ICON plc , (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will provide a live webcast of its Analyst Day meeting which will take place on Thursday, March 17, 2022 in Blue Bell, Philadelphia, starting at 12.30pm ET. T...

ICLR - ICON Public Limited Company (ICLR) CEO Steve Cutler on Q4 2021 Results - Earnings Call Transcript

ICON Public Limited Company (ICLR) Q4 2021 Earnings Conference Call February 22, 2022, 9:00 AM ET Company Participants Steve Cutler – Chief Executive Officer Brendan Brennan – Chief Financial Officer Kate Haven – Vice President Investor Relations Conference Call Participa...

ICLR - Icon GAAP EPS of $2.63 beats by $1.01, revenue of $1.89B misses by $10M

Icon press release (NASDAQ:ICLR): Q4 GAAP EPS of $2.63 beats by $1.01. Revenue of $1.89B (+148.6% Y/Y) misses by $10M. Adjusted revenue of $1,881.1 million representing a year on year increase of 147.4%.  Adjusted EBITDA  was $332.5M or 17.7% of revenue, a year on year increase of 1...

Previous 10 Next 10